July 2016 Issue of Renal And Urology News
RUN June-July 2016 Cover
Nephrology Cover Articles
After adjusting for potential confounders and mediators, a large cross-sectional study found no association between obesity and CKD prevalence.
Use of the lipid-lowering drugs is associated with 43% and 47% decreased odds of new stones in recurrent stone formers and stone naïve patients.
Study demonstrates improved 90-day survival and greater likelihood of recovering renal function.
Urology Cover Articles
The PLCO trial's conclusion that routine PSA testing does not affect prostate cancer mortality risk could be wrong.
In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.
Technique could reduce the need for ureteral access sheaths.
It is unclear to physicians why some patients develop calciphylaxis while others do not.
The control of phosphorus is underappreciated, for example.
News in Brief
The condition is associated with a death risk similar to that of apparent hypercalcemia.
The 15-hour surgery took place in early May.
Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.
Researchers find an increased risk of death among patients.
De novo OAB — defined as urgency with or without frequency and nocturia — developed in some patients.
Patients with non-dialysis chronic kidney disease (CKD) may be at elevated risk for hip fracture, according the Journal of Bone and Mineral Research.
Prompt-pay discounts and payment plans are among the ways practices can improve collections of what patients owe.
Researchers linked the condition to warfarin use, diabetes, obesity, recurrent skin trauma, and derangements in mineral metabolism.
PCNL procedure rate nearly doubles over a 2-decade period, study finds.
Recommendations for diagnosing and managing non-muscle invasive bladder cancer promise to allow for more individualized patient care.
Investigators find that the normalized mean ESA dose decreases as patients' elevation of residence increases.
Average 6-month serum phosphorus level was significantly lower in CKD patients who received niacin than those who did not (3.4 vs. 4.2 mg/dL).
The study is the first to find a link between FGF23 levels and infection in non-dialysis patients.
Findings support the use of a 5 grade-group system that more accurately reflects patient risk of adverse outcomes.
New study shows that heavier comorbidity burdens increase the risk of Gleason 7 or higher tumors being found at biopsy.
LUTS is 49% more likely to develop in men with a PSA level above 6 ng/mL versus 4 ng/mL or less.
New data show that the minimally invasive procedure is superior overall to TURP for treating BPH-related lower urinary tract symptoms.
In a study of African-American radical prostatectomy patients, low income predicted a higher risk of advanced stage or aggressive tumors.
New findings show metabolic changes suggesting that a carbohydrate-restricted diet may improve insulin sensitivity.
Reasons are unclear, but use of testosterone and other performance enhance drugs could be a contributing factor.
Minimally invasive surgery is associated with a lower incidence of bladder neck contracture.
Study documents significant improvements in frequency, urgency, and nocturia.
Paricalcitol-based protocol includes limited use of calcium-based phosphate binders.
Phosphorus levels are higher when blood specimens are collected after weekends.
Odds of non-fatal stroke are 49% higher in patients in the fourth quartile of uric acid level versus those in the second quartile.
Male gender, diabetes, and renal function decline at 90 days implicated as risk factors; patients rarely progress to end-stage renal disease.
New findings show that current smokers had an 83% higher incidence of rapid renal function decline compared with never smokers.
Researchers find an increased risk for elevated serum creatinine, but not chronic kidney disease or all-cause mortality.
The researchers found no relationship between poor quality of life and CKD progression.
High vs. low fitness levels in midlife lowered CKD risk in later life by 34%.
A recent study suggests that sodium thiosulfate may be an effective treatment for calciphylaxis.
Renal and Urology News Articles
- Mediterranean Diet Best for Lowering Aggressive Prostate Cancer Risk
- SABR for Renal Cell Carcinoma Offers Excellent Outcomes
- Radical Cystectomy Offers Better Long-term MIBC Patient Survival
- Robotic Kidney Transplantation Safe, Feasible
- Most CKD Patients With Anemia Show Limited Response to Oral Iron
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)